HLA-C and neoplasm: We believe that while the T cell response is often regarded as the primary anti-tumor effector mechanism, antibody responses are also important as major histocompatibility complex (MHC) downregulation and epitope loss, observed in some tumors, would render them resistant to T cell-mediated cell death [39].